jerryking + marketing + pharmacy-benefit_management   1

The New Innovator’s Dilemma: When Customers Won’t Pay for Better - WSJ
Aug. 15, 2017 | WSJ | By Denise Roland.

As the turmoil at Novo Nordisk shows, there are commercial limits to innovation. Nokia Corp. and BlackBerry Ltd. both lost their market dominance in smartphones because competitors beat them with major technological advances. Both firms are in the process of reinventing themselves.

In other cases, though, innovation has hit a wall. That is especially the case in some pockets of the pharmaceuticals business, where the scope for big improvements is narrowing.
CDC  Novo_Nordisk  innovation  pricing  marketing  strategy  insulin  diabetes  Denmark  Danish  pharmaceutical_industry  pharmacy-benefit_management 
august 2017 by jerryking

Copy this bookmark:



description:


tags: